Wanbangde Pharmaceutical Holding Group Co.Ltd(002082)
Annual report for 2021
April 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Zhao Shouming, the person in charge of the company, Zhao Junhui, the person in charge of accounting, and Shi Huihong, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
This annual report involves forward-looking statements such as future plans, which does not constitute the company’s substantive commitment to investors. Investors and relevant persons should maintain sufficient risk awareness and understand the differences between plans, forecasts and commitments.
The company has risks such as macroeconomic cyclical fluctuations, national policy adjustments, raw material prices and product R & D, market competition, etc. for details, see “Xi. Future development prospects of the company” in “section III Management Discussion and analysis” of this report. The company invites investors to carefully read this report and invites investors to pay attention to investment risks.
The company’s profit distribution plan reviewed and approved by the board of directors is: take 613222829 as the base, distribute cash dividend of 0.00 yuan (including tax) to all shareholders for every 10 shares, send bonus shares of 0 share (including tax), and do not use the accumulation fund to increase the share capital.
catalogue
Section I important tips, contents and definitions Section 2 company profile and main financial indicators Section III Management Discussion and Analysis Section IV corporate governance 49 Section V environmental and social responsibility Section VI important matters Section VII share changes and shareholders Section VIII preferred shares Section IX related information of bonds 101 section x financial report one hundred and two
Directory of documents for future reference
1、 The full text of the company’s 2021 annual report signed by the chairman;
2、 Accounting statements containing the signatures and seals of the legal representative of the company, the person in charge of accounting and the person in charge of accounting institutions;
3、 The original audit report with the signature and seal of the certified public accountant;
4、 During the reporting period, securities times, Securities Daily, Shanghai Securities News, China Securities News and designated information disclosure websites: http://www.cn.info.com.cn. The originals of all company documents and announcements disclosed by the company.
The above documents shall be kept in the Securities Department of the company for future reference
